Development of fragment-specific osteopontin antibodies and ELISA for quantification in human metastatic breast cancer

BACKGROUND: Osteopontin (OPN) is associated with human cancers, and circulating blood OPN may have diagnostic or prognostic value in clinical oncology. METHODS: To evaluate OPN as a cancer biomarker, we generated and characterized five novel mouse monoclonal antibodies against the human full-length...

Descripción completa

Detalles Bibliográficos
Autores principales: Plumer, Alicia, Duan, Hongyi, Subramaniam, Sripriya, Lucas, F Lee, Miesfeldt, Susan, Ng, Ah-Kau, Liaw, Lucy
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259319/
https://www.ncbi.nlm.nih.gov/pubmed/18237408
http://dx.doi.org/10.1186/1471-2407-8-38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259319/
https://www.ncbi.nlm.nih.gov/pubmed/18237408
http://dx.doi.org/10.1186/1471-2407-8-38

Ejemplares similares